NCT06684314 - A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

August 28, 2031

Study Completion Date

August 28, 2031

Conditions

Hemophilia A

Interventions

DRUG

Efanesoctocog alfa

This study will not administer any treatment, only observe the treatment as prescribed in real-world clinical practices.

Trial Locations (10)

RECRUITING

Investigational Site Number : 1580001, Taipei

RECRUITING

Investigational Site Number : 1580003, Taipei

RECRUITING

Investigational Site Number : 1580002, Taipei

RECRUITING

Investigational Site Number : 1580008, Changhua

RECRUITING

Investigational Site Number : 1580009, Kaohsiung City

RECRUITING

Investigational Site Number : 1580004, Taoyuan

RECRUITING

Investigational Site Number : 1580005, Taichung

RECRUITING

Investigational Site Number : 1580006, Taichung

RECRUITING

Investigational Site Number : 1580007, Taichung

RECRUITING

Investigational Site Number : 1580010, Kaohsiung City